Cargando…

Two years of treatment with the recombinant grass pollen allergy vaccine BM32 induces a continuously increasing allergen-specific IgG(4) response

BACKGROUND: BM32, a grass pollen allergy vaccine containing four recombinant fusion proteins consisting of hepatitis B-derived PreS and hypoallergenic peptides from the major timothy grass pollen allergens adsorbed on aluminium hydroxide has been shown to be safe and to improve clinical symptoms of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eckl-Dorna, Julia, Weber, Milena, Stanek, Victoria, Linhart, Birgit, Ristl, Robin, Waltl, Eva E., Villazala-Merino, Sergio, Hummel, Andrea, Focke-Tejkl, Margarete, Froeschel, Renate, Neubauer, Angela, Henning, Rainer, Perkmann, Thomas, Valenta, Rudolf, Niederberger, Verena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Research paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921329/ https://www.ncbi.nlm.nih.gov/pubmed/31786130 http://dx.doi.org/10.1016/j.ebiom.2019.11.006

Ejemplares similares

Comparison of the immunogenicity of BM32, a recombinant hypoallergenic B cell epitope–based grass pollen allergy vaccine with allergen extract–based vaccines
por: Weber, Milena, et al.
Publicado: (2017)

Antibody Conjugates Bispecific for Pollen Allergens and ICAM-1 with Potential to Prevent Epithelial Allergen Transmigration and Rhinovirus Infection
por: Weichwald, Christina, et al.
Publicado: (2023)

Safety and efficacy of immunotherapy with the recombinant B-cell epitope–based grass pollen vaccine BM32
por: Niederberger, Verena, et al.
Publicado: (2018)

Allergen Microarray Indicates Pooideae Sensitization in Brazilian Grass Pollen Allergic Patients
por: Moreira, Priscila Ferreira de Sousa, et al.
Publicado: (2015)

A B Cell Epitope Peptide Derived from the Major Grass Pollen Allergen Phl p 1 Boosts Allergen-Specific Secondary Antibody Responses without Allergen-Specific T Cell Help
por: Narayanan, Meena, et al.
Publicado: (2017)

Allergen-Specific Antibodies Regulate Secondary Allergen-Specific Immune Responses
por: Eckl-Dorna, Julia, et al.
Publicado: (2019)

Detection of genuine grass pollen sensitization in children by skin testing with a recombinant grass pollen hybrid
por: Douladiris, Nikolaos, et al.
Publicado: (2018)

Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy
por: Focke-Tejkl, Margarete, et al.
Publicado: (2015)

Allergen Peptides, Recombinant Allergens and Hypoallergens for Allergen-Specific Immunotherapy
por: Marth, Katharina, et al.
Publicado: (2014)

Preventive Administration of Non-Allergenic Bet v 1 Peptides Reduces Allergic Sensitization to Major Birch Pollen Allergen, Bet v 1
por: Akinfenwa, Oluwatoyin, et al.
Publicado: (2021)

Trimolecular complex between major birch pollen allergen, Bet v 1, monoclonal allergen-specific human IgE and recombinant CD23
por: Selb, Regina, et al.
Publicado: (2014)

Multiple independent IgE epitopes on the highly allergenic grass pollen allergen Phl p 5
por: Levin, M, et al.
Publicado: (2014)

Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: Lessons from the past and novel mechanisms of action for the future
por: Valenta, Rudolf, et al.
Publicado: (2016)

Allergen-specific IgE levels and the ability of IgE-allergen complexes to cross-link determine the extent of CD23-mediated T-cell activation
por: Villazala-Merino, Sergio, et al.
Publicado: (2019)

Poor association of allergen‐specific antibody, T‐ and B‐cell responses revealed with recombinant allergens and a CFSE dilution‐based assay
por: Eckl‐Dorna, J., et al.
Publicado: (2015)

Characterisation and culture of primary human nasal epithelial cells and the influence of Interferon-gamma
por: Waltl, Eva, et al.
Publicado: (2014)

Expression and characterization of recombinant Par j 1 and Par j 2 resembling the allergenic epitopes of Parietaria judaica pollen
por: Dorofeeva, Yulia, et al.
Publicado: (2019)

Prophylactic and therapeutic vaccination with carrier-bound Bet v 1 peptides lacking allergen-specific T cell epitopes reduces Bet v 1-specific T cell responses via blocking antibodies in a murine model for birch pollen allergy
por: Linhart, B, et al.
Publicado: (2014)

Primary Nasal Epithelial Cells From Allergic and Non-allergic Individuals Show Comparable Barrier Function
por: Waltl, Eva E., et al.
Publicado: (2019)

Recombinant allergen-based provocation testing()
por: Niederberger, Verena, et al.
Publicado: (2014)

Characterisation of recombinant CD23 in the trimeric complex with IgE and allergen
por: Selb, Regina Maria, et al.
Publicado: (2015)

Establishment of a cell culture model based on primary epithelial cells to investigate damage and repair of respiratory epithelial cells
por: Waltl, Eva E, et al.
Publicado: (2015)

Highly sensitive ELISA‐based assay for quantification of allergen‐specific IgE antibody levels
por: Karsonova, Antonina, et al.
Publicado: (2020)

Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergy
por: Zieglmayer, Petra, et al.
Publicado: (2016)

Critical and direct involvement of the CD23 stalk region in IgE binding
por: Selb, Regina, et al.
Publicado: (2016)

Immunotherapy With the PreS-based Grass Pollen Allergy Vaccine BM32 Induces Antibody Responses Protecting Against Hepatitis B Infection
por: Cornelius, Carolin, et al.
Publicado: (2016)

Antibody conjugates bispecific for intercellular adhesion molecule 1 and allergen prevent migration of allergens through respiratory epithelial cell layers
por: Madritsch, Christoph, et al.
Publicado: (2015)

Allergen Extracts for In Vivo Diagnosis and Treatment of Allergy: Is There a Future?
por: Valenta, Rudolf, et al.
Publicado: (2018)

From Allergen Molecules to Molecular Immunotherapy of Nut Allergy: A Hard Nut to Crack
por: Fuhrmann, Verena, et al.
Publicado: (2021)

Antibodies induced by immunization with a hypoallergenic mutant of the major fish allergen Cyp c 1 inhibit allergic symptoms in a mouse model of fish allergy
por: Gstoettner, AC, et al.
Publicado: (2013)

Biochemical, Biophysical and IgE-Epitope Characterization of the Wheat Food Allergen, Tri a 37
por: Pahr, Sandra, et al.
Publicado: (2014)

The Molecular Allergen Recognition Profile in China as Basis for Allergen-Specific Immunotherapy
por: D’souza, Nishelle, et al.
Publicado: (2021)

Sensitization to timothy grass pollen allergenic molecules in children
por: Scaparrotta, Alessandra, et al.
Publicado: (2013)

Differences in grass pollen allergen exposure across Australia
por: Beggs, Paul J., et al.
Publicado: (2015)

Quantification, epitope mapping and genotype cross-reactivity of hepatitis B preS-specific antibodies in subjects vaccinated with different dosage regimens of BM32
por: Tulaeva, Inna, et al.
Publicado: (2020)

Tracing Human IgE B Cell Antigen Receptor-Bearing Cells With a Monoclonal Anti-Human IgE Antibody That Specifically Recognizes Non-Receptor-Bound IgE
por: Zghaebi, Mohammed, et al.
Publicado: (2021)

Effects of Nasal Corticosteroids on Boosts of Systemic Allergen-Specific IgE Production Induced by Nasal Allergen Exposure
por: Egger, Cornelia, et al.
Publicado: (2015)

Treatment of grass pollen allergy: focus on a standardized grass allergen extract – Grazax(®)
por: Calderón, Moisés, et al.
Publicado: (2008)

Clinical Results from Vaccination With Recombinant Grass Pollen Allergens
por: Jutel, Marek, et al.
Publicado: (2006)

A Group-1 Grass Pollen Allergen Influences the Outcome of Pollen Competition in Maize
por: Valdivia, Elene R., et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_7puvmevk6n4kb5mds71h9b37mc